
    
      The trial will be cross over, randomized in incomplete blocks, controlled, double-blind:

      each subject will be administered 3 products out of 4 (positive control, probiotic
      Streptococcus (S.) thermophilus, probiotic Bifidobacterium (B.) longum, negative control) in
      a random order on 3 different days separated by a washout period of at least one week, and
      maximum 2 weeks between each challenge.

      The total sample size is 42 enrolled subjects/37 completed Patients will be males and females
      aged between 20 and 65 years with positive hydrogen breath test.
    
  